The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Open accessAbstract
Pseudomonas aeruginosa is an opportunistic pathogen that is a leading cause of morbidity and mortality in cystic fibrosis patients and immunocompromised individuals. Eradication of P. aeruginosa has become increasingly difficult due to its remarkable capacity to resist antibiotics. Strains of Pseudomonas aeruginosa are known to utilize their high levels of intrinsic and acquired resistance mechanisms to counter most antibiotics. In addition, adaptive antibiotic resistance of P. aeruginosa is a recently characterized mechanism, which includes biofilm-mediated resistance and formation of multidrug-tolerant persister cells, and is responsible for recalcitrance and relapse of infections. The discovery and development of alternative therapeutic strategies that present novel avenues against P. aeruginosa infections are increasingly demanded and gaining more and more attention. Although mostly at the preclinical stages, many recent studies have reported several innovative therapeutic technologies that have demonstrated pronounced effectiveness in fighting against drug-resistant P. aeruginosa strains. This review highlights the mechanisms of antibiotic resistance in P. aeruginosa and discusses the current state of some novel therapeutic approaches for treatment of P. aeruginosa infections that can be further explored in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The acquisition of drug resistance by P. aeruginosa depends primarily on multiple intrinsic and acquired antibiotic resistance mechanisms, including the biofilm-mediated formation of resistant and multi-drug-resistant persistent cells.223”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [223]
In the citing paper
“Meanwhile, P. aeruginosa infection can also cope with antibiotic treatment by forming persistent cells or persisters, thereby preventing the synthesis of antibiotic targets.223,262,263”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [223]
In the citing paper
“P. aeruginosa have strong ability to develop natural and acquired drug resistance through various mechanisms, including the production of antibiotic inactivating enzymes or antibiotic modifying enzymes, inhibiting the penetration of the drug through the cell wall, changing the target of antibacterial action, and limiting the drug to reach its target and adaptation to the adverse environment.223”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [223]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Webb, A. K. (2006) · Cited by 4,369
Biofilms: Microbial Life on Surfaces
Donlan, R. M. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0809.020063 · Cited by 4,145
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.98 · Cited by 3,297
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Applications of nanoparticles in biology and medicine
Salata, O. (2004) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-2-3 · Cited by 2,327
Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control
Rutherford, S. T., & Bassler, B. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012427 · Cited by 2,129
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Principles of c-di-GMP signalling in bacteria
Hengge, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2109 · Cited by 1,578
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Mechanisms of antibiotic resistance in bacterial biofilms
Stewart, P. S. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00196 · Cited by 1,385
The hierarchy quorum sensing network in Pseudomonas aeruginosa
Lee, J., & Zhang, L. (2015) · Protein & Cell · doi:10.1007/s13238-014-0100-x · Cited by 1,346
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Clokie, M. R. J., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011) · Bacteriophage · doi:10.4161/bact.1.1.14942 · Cited by 1,149
Aminoglycosides: Activity and Resistance
Mingeot-Leclercq, M.-P., Glupczynski, Y., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.727 · Cited by 1,113
Bacterial Quorum Sensing in Pathogenic Relationships
de Kievit, T. R., & Iglewski, B. H. (2000) · Infection and Immunity · doi:10.1128/iai.68.9.4839-4849.2000 · Cited by 1,110
Hentzer, M., Riedel, K., Rasmussen, T. B., Heydorn, A., Andersen, J. B., Parsek, M. R., Rice, S. A., Eberl, L., Molin, S., Høiby, N., et al. (2002) · Microbiology · doi:10.1099/00221287-148-1-87 · Cited by 1,050
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997
Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria
Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., et al. (2011) · Science · doi:10.1126/science.1211037 · Cited by 978
Quorum sensing inhibitors: An overview
Kalia, V. C. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.10.004 · Cited by 971
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Pseudomonas genomes: diverse and adaptable
Silby, M. W., Winstanley, C., Godfrey, S. A. C., Levy, S. B., & Jackson, R. W. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00269.x · Cited by 960
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Anderl, J. N., Franklin, M. J., & Stewart, P. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1818-1824.2000 · Cited by 958
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
The immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2749 · Cited by 919
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Elsaesser, A., & Howard, C. V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.001 · Cited by 895
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Citorik, R. J., Mimee, M., & Lu, T. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.3011 · Cited by 808
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
Dörr, T., Vulić, M., & Lewis, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000317 · Cited by 782
Mobile gene cassettes and integrons: capture and spread of genes by site‐specific recombination
Hall, R. M., & Collis, C. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02368.x · Cited by 774
Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Sun, J., Deng, Z., & Yan, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.090 · Cited by 746
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
Bacterial Persister Cell Formation and Dormancy
Wood, T. K., Knabel, S. J., & Kwan, B. W. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02636-13 · Cited by 703
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.
Lambert, P. A. (2002) · Europe PMC (PubMed Central) · Cited by 677
Toxicology and clinical potential of nanoparticles
Yildirimer, L., Thanh, N. T. K., Loizidou, M., & Seifalian, A. M. (2011) · Nano Today · doi:10.1016/j.nantod.2011.10.001 · Cited by 676
Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E., & Singh, P. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30783 · Cited by 661
Molecular Mechanisms Underlying Bacterial Persisters
Maisonneuve, E., & Gerdes, K. (2014) · Cell · doi:10.1016/j.cell.2014.02.050 · Cited by 645
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Goodman, A. L., Kulasekara, B., Rietsch, A., Boyd, D., Smith, R. S., & Lory, S. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.08.020 · Cited by 628
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease
Miller, M. R., Raftis, J. B., Langrish, J. P., McLean, S. G., Samutrtai, P., Connell, S. P., Wilson, S., Vesey, A. T., Fokkens, P. H. B., Boere, A. J. F., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b08551 · Cited by 609
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Extended-spectrum ß-lactamases in gram negative bacteria
Rawat, D., & Nair, D. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.68531 · Cited by 588
Nanoparticles: Health Effects—Pros and Cons
Gwinn, M. R., & Vallyathan, V. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8871 · Cited by 571
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Rasamiravaka, T., Labtani, Q., Duez, P., & El Jaziri, M. (2015) · BioMed Research International · doi:10.1155/2015/759348 · Cited by 546
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
The phage‐host arms race: Shaping the evolution of microbes
Stern, A., & Sorek, R. (2011) · BioEssays · doi:10.1002/bies.201000071 · Cited by 527
Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture
Ghafoor, A., Hay, I. D., & Rehm, B. H. A. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00637-11 · Cited by 524
Quorum sensing inhibitors: a bargain of effects
Rasmussen, T. B., & Givskov, M. (2006) · Microbiology · doi:10.1099/mic.0.28601-0 · Cited by 523
Antimicrobial resistance of Pseudomonas aeruginosa biofilms
Drenkard, E. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.08.009 · Cited by 520
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Hancock, R. E. W., & Speert, D. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0152 · Cited by 515
Merabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., Van Parys, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004944 · Cited by 511
Role of Iron in Bacterial Infection
Bullen, J. J., Rogers, H. J., & Griffiths, E. (1978) · Modern Aspects of Electrochemistry · doi:10.1007/978-3-642-66956-9_1 · Cited by 492
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Anti-adhesion therapy of bacterial diseases: prospects and problems
Ofek, I., Hasty, D. L., & Sharon, N. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00228-1 · Cited by 444
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Wang, X., & Wood, T. K. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05068-11 · Cited by 433
Genetically Engineered Phages: a Review of Advances over the Last Decade
Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., & Lu, T. K. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00069-15 · Cited by 427
Brown, A. N., Smith, K., Samuels, T. A., Lu, J., Obare, S. O., & Scott, M. E. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.06513-11 · Cited by 420
Moskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Hirsch, E. B., & Tam, V. H. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.49 · Cited by 406
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Tielker, D., Hacker, S., Loris, R., Strathmann, M., Wingender, J., Wilhelm, S., Rosenau, F., & Jaeger, K.-E. (2005) · Microbiology · doi:10.1099/mic.0.27701-0 · Cited by 386
Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics
Zhang, L., & Mah, T.-F. (2008) · Journal of Bacteriology · doi:10.1128/jb.01655-07 · Cited by 385
Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections
Cornelis, P., & Dingemans, J. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00075 · Cited by 382
Formation, physiology, ecology, evolution and clinical importance of bacterial persisters
Van den Bergh, B., Fauvart, M., & Michiels, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux001 · Cited by 381
Medical Applications and Toxicities of Gallium Compounds
Chitambar, C. R. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7052337 · Cited by 380
The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa
Diggle, S. P., Stacey, R. E., Dodd, C., Cámara, M., Williams, P., & Winzer, K. (2006) · Environmental Microbiology · doi:10.1111/j.1462-2920.2006.001001.x · Cited by 375
Fu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., & Donlan, R. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00669-09 · Cited by 362
Resistance to ?-lactam antibiotics
Poole, K. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4060-9 · Cited by 358
Pseudomonas aeruginosa Genomic Structure and Diversity
Klockgether, J., Cramer, N., Wiehlmann, L., Davenport, C. F., & Tümmler, B. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00150 · Cited by 354
Taylor, P. K., Yeung, A. T. Y., & Hancock, R. E. W. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.09.003 · Cited by 340
Toxin–antitoxin systems: Biology, identification, and application
Unterholzner, S. J., Poppenberger, B., & Rozhon, W. (2013) · Mobile Genetic Elements · doi:10.4161/mge.26219 · Cited by 334
Antibacterial effect of silver nanoparticles in Pseudomonas aeruginosa
Salomoni, R., Léo, P., Montemor, A., Rinaldi, B., & Rodrigues, M. (2017) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s133415 · Cited by 334
The factors affecting effectiveness of treatment in phages therapy
Ly-Chatain, M. H. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00051 · Cited by 331
Park, S.-C., Park, Y., & Hahm, K.-S. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095971 · Cited by 327
Role of extracellular DNA in initial bacterial adhesion and surface aggregation
Das, T., Sharma, P. K., Busscher, H. J., van der Mei, H. C., & Krom, B. P. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.03119-09 · Cited by 326
Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerová, M., Guery, B. P., & Faure, K. (2009) · Infection and Immunity · doi:10.1128/iai.01204-08 · Cited by 325
Antimicrobial peptides: New candidates in the fight against bacterial infections
Toke, O. (2005) · Peptide Science · doi:10.1002/bip.20286 · Cited by 322
Function of Pseudomonas Porins in Uptake and Efflux
Hancock, R. E. W., & Brinkman, F. S. L. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160310 · Cited by 319
Paczkowski, J. E., Mukherjee, S., McCready, A. R., Cong, J.-P., Aquino, C. J., Kim, H., Henke, B. R., Smith, C. D., & Bassler, B. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770552 · Cited by 319
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Chatterjee, M., Anju, C. P., Biswas, L., Anil Kumar, V., Gopi Mohan, C., & Biswas, R. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.11.004 · Cited by 312
Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system
Høyland-Kroghsbo, N. M., Paczkowski, J., Mukherjee, S., Broniewski, J., Westra, E., Bondy-Denomy, J., & Bassler, B. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617415113 · Cited by 312
c-di-GMP and its Effects on Biofilm Formation and Dispersion: a Pseudomonas Aeruginosa Review
Ha, D.-G., & O'Toole, G. A. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0003-2014 · Cited by 306
Davies, J. C., Alton, E. W. F. W., & Bush, A. (2007) · BMJ · doi:10.1136/bmj.39391.713229.ad · Cited by 306
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence
Davies, J. C. (2002) · Paediatric Respiratory Reviews · doi:10.1016/s1526-0550(02)00003-3 · Cited by 300
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
Chung, P. Y., & Khanum, R. (2017) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2016.12.005 · Cited by 296
Lamers, R. P., Cavallari, J. F., & Burrows, L. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060666 · Cited by 291
Cady, K. C., Bondy-Denomy, J., Heussler, G. E., Davidson, A. R., & O'Toole, G. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.01184-12 · Cited by 287
Barbier, F., Andremont, A., Wolff, M., & Bouadma, L. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835f27be · Cited by 281
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1797-1802.2004 · Cited by 277
Morello, E., Saussereau, E., Maura, D., Huerre, M., Touqui, L., & Debarbieux, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016963 · Cited by 275
Das, T., Sehar, S., & Manefield, M. (2013) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12085 · Cited by 274
Starkey, M., Lepine, F., Maura, D., Bandyopadhaya, A., Lesic, B., He, J., Kitao, T., Righi, V., Milot, S., Tzika, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004321 · Cited by 273
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
Hong, D. J., Bae, I. K., Jang, I.-H., Jeong, S. H., Kang, H.-K., & Lee, K. (2015) · Infection & Chemotherapy · doi:10.3947/ic.2015.47.2.81 · Cited by 271
Berrazeg, M., Jeannot, K., Ntsogo Enguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-15 · Cited by 268
HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase
Kaspy, I., Rotem, E., Weiss, N., Ronin, I., Balaban, N. Q., & Glaser, G. (2013) · Nature Communications · doi:10.1038/ncomms4001 · Cited by 268
Li, H., Luo, Y.-F., Williams, B. J., Blackwell, T. S., & Xie, C.-M. (2012) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.10.001 · Cited by 266
Johansson, E. M. V., Crusz, S. A., Kolomiets, E., Buts, L., Kadam, R. U., Cacciarini, M., Bartels, K.-M., Diggle, S. P., Cámara, M., Williams, P., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.009 · Cited by 263
A problem of persistence: still more questions than answers?
Balaban, N. Q., Gerdes, K., Lewis, K., & McKinney, J. D. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3076 · Cited by 263
Parkins, M. D., Ceri, H., & Storey, D. G. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02469.x · Cited by 263
Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., & Walsh, T. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4654-4661.2004 · Cited by 261
Macfarlane, E. L. A., Kwasnicka, A., Ochs, M. M., & Hancock, R. E. W. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01600.x · Cited by 254
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Aoki, W., & Ueda, M. (2013) · Pharmaceuticals · doi:10.3390/ph6081055 · Cited by 252
Kim, Y., & Wood, T. K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.033 · Cited by 246
Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa
Wilton, M., Charron-Mazenod, L., Moore, R., & Lewenza, S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01650-15 · Cited by 246
Möker, N., Dean, C. R., & Tao, J. (2010) · Journal of Bacteriology · doi:10.1128/jb.01231-09 · Cited by 245
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
Chastre, J., Wunderink, R., Prokocimer, P., Lee, M., Kaniga, K., & Friedland, I. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181691b99 · Cited by 237
Innate immune responses to Pseudomonas aeruginosa infection
Lavoie, E. G., Wangdi, T., & Kazmierczak, B. I. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.07.011 · Cited by 235
Innate immunity in cystic fibrosis lung disease
Hartl, D., Gaggar, A., Bruscia, E., Hector, A., Marcos, V., Jung, A., Greene, C., McElvaney, G., Mall, M., & Döring, G. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.07.003 · Cited by 230
Targeting the bacteria–host interface: Strategies in anti-adhesion therapy
Krachler, A. M., & Orth, K. (2013) · Virulence · doi:10.4161/viru.24606 · Cited by 228
Dosler, S., & Karaaslan, E. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.021 · Cited by 226
Miller, A. K., Brannon, M. K., Stevens, L., Johansen, H. K., Selgrade, S. E., Miller, S. I., Høiby, N., & Moskowitz, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05391-11 · Cited by 224
Westwater, C., Kasman, L. M., Schofield, D. A., Werner, P. A., Dolan, J. W., Schmidt, M. G., & Norris, J. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1301-1307.2003 · Cited by 214
Tripartite assembly of RND multidrug efflux pumps
Daury, L., Orange, F., Taveau, J.-C., Verchère, A., Monlezun, L., Gounou, C., Marreddy, R. K. R., Picard, M., Broutin, I., Pos, K. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms10731 · Cited by 213
Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
Waters, E. M., Neill, D. R., Kaman, B., Sahota, J. S., Clokie, M. R. J., Winstanley, C., & Kadioglu, A. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209265 · Cited by 212
Combination Strategies to Enhance the Efficacy of Antimicrobial Peptides against Bacterial Biofilms
Grassi, L., Maisetta, G., Esin, S., & Batoni, G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02409 · Cited by 212
Toxin-Antitoxin systems: their role in persistence, biofilm formation, and pathogenicity
Wen, Y., Behiels, E., & Devreese, B. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12145 · Cited by 209
Cabot, G., Zamorano, L., Moyá, B., Juan, C., Navas, A., Blázquez, J., & Oliver, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02676-15 · Cited by 208
Moreau-Marquis, S., O'Toole, G. A., & Stanton, B. A. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0299oc · Cited by 204
Roles of Pseudomonas aeruginosa las and rhl Quorum-Sensing Systems in Control of Twitching Motility
Glessner, A., Smith, R. S., Iglewski, B. H., & Robinson, J. B. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.5.1623-1629.1999 · Cited by 204
Inhibition of Quorum Sensing in Pseudomonas aeruginosa by N -Acyl Cyclopentylamides
Ishida, T., Ikeda, T., Takiguchi, N., Kuroda, A., Ohtake, H., & Kato, J. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02233-06 · Cited by 193
Identification and characterization of porins in Pseudomonas aeruginosa.
Nikaido, H., Nikaido, K., & Harayama, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35239-0 · Cited by 190
Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
Dreier, J., & Ruggerone, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00660 · Cited by 189
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Döring, G., Meisner, C., Stern, M., & for the Flagella Vaccine Trial Study Group (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702403104 · Cited by 186
Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
Pires, D. P., Vilas Boas, D., Sillankorva, S., & Azeredo, J. (2015) · Journal of Virology · doi:10.1128/jvi.00385-15 · Cited by 185
Anti-biofilm peptides as a new weapon in antimicrobial warfare
Pletzer, D., Coleman, S. R., & Hancock, R. E. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.016 · Cited by 184
Molecular Basis of Azithromycin-Resistant Pseudomonas aeruginosa Biofilms
Gillis, R. J., White, K. G., Choi, K.-H., Wagner, V. E., Schweizer, H. P., & Iglewski, B. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3858-3867.2005 · Cited by 183
Henrichfreise, B., Wiegand, I., Pfister, W., & Wiedemann, B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00148-07 · Cited by 179
Hocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., Lomovskaya, O., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1371-1375.2003 · Cited by 177
Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials
Vandenheuvel, D., Lavigne, R., & Brüssow, H. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-054915 · Cited by 176
Riera, E., Cabot, G., Mulet, X., Garcia-Castillo, M., del Campo, R., Juan, C., Canton, R., & Oliver, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr232 · Cited by 175
Juan, C., Maciá, M. D., Gutiérrez, O., Vidal, C., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4733-4738.2005 · Cited by 175
Yang, L., Nilsson, M., Gjermansen, M., Givskov, M., & Tolker‐Nielsen, T. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06934.x · Cited by 172
Update on the treatment of Pseudomonas aeruginosa pneumonia
El Solh, A. A., & Alhajhusain, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp201 · Cited by 172
Fong, S. A., Drilling, A., Morales, S., Cornet, M. E., Woodworth, B. A., Fokkens, W. J., Psaltis, A. J., Vreugde, S., & Wormald, P.-J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00418 · Cited by 164
Promises and Failures of Gallium as an Antibacterial Agent
Minandri, F., Bonchi, C., Frangipani, E., Imperi, F., & Visca, P. (2014) · Future Microbiology · doi:10.2217/fmb.14.3 · Cited by 163
Srikumar, R., Paul, C. J., & Poole, K. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.5.1410-1414.2000 · Cited by 160
Vaccines for Pseudomonas aeruginosa : a long and winding road
Priebe, G. P., & Goldberg, J. B. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.890053 · Cited by 159
Adaptive resistance to antibiotics in bacteria: a systems biology perspective
Sandoval‐Motta, S., & Aldana, M. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1335 · Cited by 159
Pseudomonas aeruginosa defends against phages through type IV pilus glycosylation
Harvey, H., Bondy‐Denomy, J., Marquis, H., Sztanko, K. M., Davidson, A. R., & Burrows, L. L. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0061-y · Cited by 154
Interfering with Bacterial Quorum Sensing
Reuter, K., Steinbach, A., & Helms, V. (2016) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s13209 · Cited by 151
Llanes, C., Köhler, T., Patry, I., Dehecq, B., van Delden, C., & Plésiat, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-11 · Cited by 147
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes
Cox, G., Ejim, L. J., Stogios, P. J., Koteva, K. K., Bordeleau, E., Evdokimova, E., Sieron, A. O., Savchenko, A. V., Serio, A. W., Krause, K. M., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00001 · Cited by 145
Antivirulence activity of azithromycin in Pseudomonas aeruginosa
Imperi, F., Leoni, L., & Visca, P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00178 · Cited by 144
Bruchmann, S., Dötsch, A., Nouri, B., Chaberny, I. F., & Häußler, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-12 · Cited by 144
Inoue, K., Takano, H., Yanagisawa, R., Hirano, S., Sakurai, M., Shimada, A., & Yoshikawa, T. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8903 · Cited by 143
Reid, D. W., Carroll, V., O'May, C. Y., Champion, A., & Kirov, S. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00154006 · Cited by 143
Grassi, L. C., Luca, M. D., Maisetta, G., Rinaldi, A. C., Esin, S., Trampuž, A., & Batoni, G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01917 · Cited by 142
Hocquet, D., Nordmann, P., Garch, F. E., Cabanne, L., & Plésiat, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1347-1351.2006 · Cited by 136
Antimicrobial Peptide GL13K Is Effective in Reducing Biofilms of Pseudomonas aeruginosa
Hirt, H., & Gorr, S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00311-13 · Cited by 129
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
Askoura, M., Mattawa, W., Abujamel, T. S., & Taher, I. (2011) · Libyan Journal of Medicine · doi:10.3402/ljm.v6i0.5870 · Cited by 127
Gallium Maltolate Treatment Eradicates Pseudomonas aeruginosa Infection in Thermally Injured Mice
DeLeon, K., Balldin, F., Watters, C., Hamood, A. N., Griswold, J., Sreedharan, S. P., & Rumbaugh, K. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01330-08 · Cited by 127
Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective
Subedi, D., Vijay, A. K., & Willcox, M. (2018) · Clinical and Experimental Optometry · doi:10.1111/cxo.12621 · Cited by 127
Storz, M. P., Maurer, C. K., Zimmer, C., Wagner, N., Brengel, C., de Jong, J. C., Lucas, S., Müsken, M., Häußler, S., Steinbach, A., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3072397 · Cited by 126
Sadovskaya, I., VINOGRADOV, E. V., Li, J., Hachani, A., Kowalska, K., & Filloux, A. (2010) · Glycobiology · doi:10.1093/glycob/cwq047 · Cited by 123
van Delden, C., Köhler, T., Brunner‐Ferber, F., François, B., Carlet, J. M., & Pechère, J.-C. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2559-3 · Cited by 122
O'May, C. Y., Sanderson, K. R., Roddam, L. F., Kirov, S. M., & Reid, D. W. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.004416-0 · Cited by 122
Guénard, S., Muller, C., Monlezun, L., Benas, P., Broutin, I., Jeannot, K., & Plésiat, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01252-13 · Cited by 119
Walkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence
Rampioni, G., Pillai, C. R., Longo, F., Bondì, R., Baldelli, V., Messina, M., Imperi, F., Visca, P., & Leoni, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-11892-9 · Cited by 114
Novel approaches to the treatment ofPseudomonas aeruginosainfections in cystic fibrosis
Hurley, M. N., Cámara, M., & Smyth, A. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00042012 · Cited by 112
Horizontal Gene Transfer among Bacteria and Its Role in Biological Evolution
Arber, W. (2014) · Life · doi:10.3390/life4020217 · Cited by 111
Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review
Ratjen, F. A., Brockhaus, F., & Angyalosi, G. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.08.004 · Cited by 109
Bellido, F., Martin, N., Siehnel, R., & Hancock, R. E. W. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.16.5196-5203.1992 · Cited by 107
MucoidPseudomonasin Cystic Fibrosis
Pritt, B. S., O’Brien, L., & Winn, W. C. (2007) · American Journal of Clinical Pathology · doi:10.1309/kjrpc7dd5tr9ntdm · Cited by 107
Pseudomonas aeruginosa Porin OprF Exists in Two Different Conformations
Sugawara, E., Nestorovich, E. M., Bezrukov, S. M., & Nikaido, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600680200 · Cited by 105
Kwon, E. J., Skalak, M., Bertucci, A., Braun, G. B., Ricci, F., Ruoslahti, E. I., Sailor, M. J., & Bhatia, S. N. (2017) · Advanced Materials · doi:10.1002/adma.201701527 · Cited by 105
Wolter, D. J. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.05.039 · Cited by 104
Örmälä, A.-M., & Jalasvuori, M. (2013) · Bacteriophage · doi:10.4161/bact.24219 · Cited by 103
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
Metadata
- Authors
- Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 37
- Issue
- 1
- Pages
- 177-192
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2903381708
- Cited by
- 2,306
- References
- 246
- FWCI
- 36.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.